- Home
- CURV vs SVRA Comparison
CURV vs SVRA Comparison
Compare CURV & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURV
- SVRA
- Stock Information
- Founded
- CURV 2001
- SVRA 2007
- Country
- CURV United States
- SVRA United States
- Employees
- CURV 7590
- SVRA N/A
- Industry
- CURV Clothing/Shoe/Accessory Stores
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- CURV Consumer Discretionary
- SVRA Health Care
- Exchange
- CURV Nasdaq
- SVRA Nasdaq
- Market Cap
- CURV 531.4M
- SVRA 528.3M
- IPO Year
- CURV 2021
- SVRA N/A
- Fundamental
- Price
- CURV $5.11
- SVRA $2.06
- Analyst Decision
- CURV Hold
- SVRA Buy
- Analyst Count
- CURV 4
- SVRA 7
- Target Price
- CURV $5.00
- SVRA $7.57
- AVG Volume (30 Days)
- CURV 242.9K
- SVRA 2.5M
- Earning Date
- CURV 06-05-2025
- SVRA 08-11-2025
- Dividend Yield
- CURV N/A
- SVRA N/A
- EPS Growth
- CURV N/A
- SVRA N/A
- EPS
- CURV 0.09
- SVRA N/A
- Revenue
- CURV $1,089,931,000.00
- SVRA N/A
- Revenue This Year
- CURV N/A
- SVRA N/A
- Revenue Next Year
- CURV N/A
- SVRA N/A
- P/E Ratio
- CURV $56.23
- SVRA N/A
- Revenue Growth
- CURV N/A
- SVRA N/A
- 52 Week Low
- CURV $2.18
- SVRA $1.89
- 52 Week High
- CURV $9.14
- SVRA $5.11
- Technical
- Relative Strength Index (RSI)
- CURV 47.29
- SVRA 34.43
- Support Level
- CURV $4.88
- SVRA $2.13
- Resistance Level
- CURV $5.22
- SVRA $2.49
- Average True Range (ATR)
- CURV 0.33
- SVRA 0.15
- MACD
- CURV 0.02
- SVRA -0.01
- Stochastic Oscillator
- CURV 54.55
- SVRA 8.41
About CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.